{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:25:45Z","timestamp":1783574745302,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18ek0510023h0002"],"award-info":[{"award-number":["18ek0510023h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jtct.2023.03.001","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T02:19:11Z","timestamp":1678069151000},"page":"365.e1-365.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Adult Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1953-8463","authenticated-orcid":false,"given":"Takaaki","family":"Konuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1018-9508","authenticated-orcid":false,"given":"Yoshimitsu","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Tanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3852-5075","authenticated-orcid":false,"given":"Junichi","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4881-0427","authenticated-orcid":false,"given":"Yoshihiro","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6850-2782","authenticated-orcid":false,"given":"Masahiro","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9609-3202","authenticated-orcid":false,"given":"Takahide","family":"Ara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1410-0830","authenticated-orcid":false,"given":"Yumiko","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8814-230X","authenticated-orcid":false,"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4969-6398","authenticated-orcid":false,"given":"Satoshi","family":"Koi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiyasu","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-4066","authenticated-orcid":false,"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1602-9775","authenticated-orcid":false,"given":"Masamitsu","family":"Yanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.03.001_bib0001","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(19)30158-9","article-title":"Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis","volume":"6","author":"Shouval","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0002","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13045-018-0655-8","article-title":"Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine","volume":"11","author":"Giannotti","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0003","doi-asserted-by":"crossref","first-page":"334.e1","DOI":"10.1016\/j.jtct.2021.01.023","article-title":"Single cord blood transplantation versus unmanipulated haploidentical transplantation for adults with acute myeloid leukemia in complete remission","volume":"27","author":"Konuma","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.03.001_bib0004","doi-asserted-by":"crossref","first-page":"710.e1","DOI":"10.1016\/j.jtct.2022.07.006","volume":"28","author":"Ruggeri","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.03.001_bib0005","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/bloodadvances.2021004462","article-title":"Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning","volume":"5","author":"Wagner","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.03.001_bib0006","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41409-022-01770-y","article-title":"Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation","volume":"57","author":"Sugita","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0007","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bjh.18530","article-title":"Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non-remission acute myeloid leukaemia: a nationwide retrospective study","volume":"201","author":"Matsuda","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0008","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bbmt.2019.10.014","article-title":"Prospective randomized study comparing myeloablative unrelated umbilical cord blood transplantation versus HLA-haploidentical related stem cell transplantation for adults with hematologic malignancies","volume":"26","author":"Sanz","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0009","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.2020007535","article-title":"Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial","volume":"137","author":"Fuchs","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.001_bib0010","doi-asserted-by":"crossref","first-page":"109.e1","DOI":"10.1016\/j.jtct.2021.11.002","article-title":"Umbilical cord blood or HLA-haploidentical transplantation: real-world outcomes versus randomized trial outcomes","volume":"28","author":"O'Donnell","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.03.001_bib0011","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/bmt.2017.34","article-title":"Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report","volume":"52","author":"Passweg","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0012","doi-asserted-by":"crossref","first-page":"e919","DOI":"10.1016\/S2352-3026(22)00293-9","article-title":"Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions","volume":"9","author":"Chang","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0013","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/hematology.2022000327","article-title":"In 2022, which is preferred: haploidentical or cord transplant?","volume":"2022","author":"Nagler","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtct.2023.03.001_bib0014","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.001_bib0015","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.bbmt.2017.06.019","article-title":"Haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide and peripheral blood stem cell grafts in older adults with acute myeloid leukemia or myelodysplastic syndrome","volume":"23","author":"Slade","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0016","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/s41409-022-01822-3","article-title":"Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation","volume":"57","author":"Atsuta","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0017","first-page":"1739","article-title":"Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation","volume":"5","author":"Gagelmann","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0018","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Milano","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.03.001_bib0019","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/bmt.2016.182","article-title":"Clinical separation of cGvHD and GvL and better GvHD-free\/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML","volume":"52","author":"Zheng","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0020","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41375-021-01474-0","article-title":"Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia","volume":"36","author":"Shimomura","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.03.001_bib0021","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/leu.2016.288","article-title":"Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation","volume":"31","author":"Kanda","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.03.001_bib0022","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1158\/1078-0432.CCR-20-4856","article-title":"Differential effect of graft-versus-host disease on survival in acute leukemia according to donor type","volume":"27","author":"Konuma","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtct.2023.03.001_bib0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","article-title":"Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation","volume":"103","author":"Kanda","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0025","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/s41409-019-0539-8","article-title":"Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience","volume":"54","author":"Yanada","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0026","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtct.2023.03.001_bib0027","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0028","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/10428194.2017.1357173","article-title":"Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients","volume":"59","author":"Yanada","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2023.03.001_bib0029","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0030","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.001_bib0031","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0032","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2013.49.5283","article-title":"Challenges of guarantee-time bias","volume":"31","author":"Giobbie-Hurder","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0033","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/sim.4780030106","article-title":"A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias","volume":"3","author":"Simon","year":"1984","journal-title":"Stat Med"},{"key":"10.1016\/j.jtct.2023.03.001_bib0034","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.seminhematol.2016.01.010","article-title":"HLA mismatching as a strategy to reduce relapse after alternative donor transplantation","volume":"53","author":"Fleischhauer","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0036","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3324\/haematol.2012.076042","article-title":"Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia","volume":"98","author":"Atsuta","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.03.001_bib0037","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00277-015-2347-6","article-title":"HLA-DRB1 mismatch is associated with a decreased relapse in adult acute myeloid leukemia after single-unit myeloablative cord blood transplantation","volume":"94","author":"Konuma","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0038","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/leu.2017.202","article-title":"HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation","volume":"32","author":"Yabe","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.03.001_bib0039","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/bmt.2013.120","article-title":"Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis","volume":"49","author":"Cunha","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbmt.2013.10.016","article-title":"Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation","volume":"20","author":"Sanz","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0041","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bbmt.2019.11.001","article-title":"Impact of HLA allele mismatch at HLA-A, -B, -C, and -DRB1 in single cord blood transplantation","volume":"26","author":"Yokoyama","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0042","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-017-0502-3","article-title":"Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis","volume":"10","author":"Chang","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0043","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/s41423-020-00597-1","article-title":"Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation","volume":"18","author":"Guo","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0044","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41409-022-01872-7","article-title":"The lower relapse rate and better survival advantages of haploidentical allograft compared with HLA-matched sibling donor allografts for intermediate- and adverse-risk AML patients with pretransplantation minimal residual disease","volume":"58","author":"Wang","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0045","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/s41375-019-0686-3","article-title":"Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study","volume":"34","author":"Yu","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.03.001_bib0046","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/leu.2015.232","article-title":"Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?","volume":"30","author":"Ringd\u00e9n","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.03.001_bib0047","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1002\/ajh.26722","volume":"97","author":"Konuma","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0048","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts","volume":"300","author":"Weiden","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.03.001_bib0049","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.001_bib0050","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.leu.2403343","article-title":"Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate","volume":"18","author":"Kanda","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.03.001_bib0051","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1200\/JCO.2012.45.0247","article-title":"Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation","volume":"31","author":"Storb","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0052","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/leu.2014.145","article-title":"Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis","volume":"28","author":"Stern","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.03.001_bib0053","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.16185","article-title":"Graft-versus-host disease and graft-versus-leukaemia effects in secondary acute myeloid leukaemia: a retrospective, multicentre registry analysis from the Acute Leukaemia Working Party of the EBMT","volume":"188","author":"Baron","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0054","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbmt.2015.09.008","article-title":"Risk factors for acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation with umbilical cord blood and matched sibling donors","volume":"22","author":"Lazaryan","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0055","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/bmt.2016.265","article-title":"GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes","volume":"52","author":"Chen","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0056","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41409-021-01493-6","article-title":"The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML","volume":"57","author":"Shimoni","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.03.001_bib0057","first-page":"1130","article-title":"Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?","volume":"111","author":"Ringd\u00e9n","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.03.001_bib0058","doi-asserted-by":"crossref","first-page":"86.e1","DOI":"10.1016\/j.jtct.2021.11.013","article-title":"Graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide versus cyclosporine A and methotrexate in matched sibling donor transplantation","volume":"28","author":"Nagler","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.03.001_bib0059","doi-asserted-by":"crossref","first-page":"211ra157","DOI":"10.1126\/scitranslmed.3006960","article-title":"Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide","volume":"5","author":"Kanakry","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtct.2023.03.001_bib0060","doi-asserted-by":"crossref","first-page":"e86252","DOI":"10.1172\/jci.insight.86252","article-title":"Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide","volume":"1","author":"Kanakry","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtct.2023.03.001_bib0061","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood-2017-05-780668","article-title":"NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications","volume":"131","author":"Russo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.001_bib0062","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1182\/blood.2021013054","article-title":"Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning","volume":"139","author":"McCurdy","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.001_bib0063","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/bloodadvances.2017014464","article-title":"Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD","volume":"2","author":"Bejanyan","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.03.001_bib0064","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/bloodadvances.2019001021","article-title":"Impact of graft sources on immune reconstitution and survival outcomes following allogeneic stem cell transplantation","volume":"4","author":"Ando","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.03.001_bib0065","doi-asserted-by":"crossref","first-page":"663.e1","DOI":"10.1016\/j.jtct.2021.04.017","volume":"27","author":"Yu","year":"2021","journal-title":"Transplant Cell Ther"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723011351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723011351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:10:29Z","timestamp":1763003429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723011351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2666636723011351"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.03.001","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Adult Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}